Genetically modified fungi kill malaria-causing parasites in mosquitoes

NIH-funded study finds way to reduce transmission of malaria to humans

2011-02-28

(Press-News.org) Spraying malaria-transmitting mosquitoes with a genetically modified fungus can kill the malaria parasite without harming the mosquito, potentially reducing malaria transmission to humans, according to a new study published in the journal Science. Funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the study was led by Raymond J. St. Leger, Ph.D., of the University of Maryland, College Park.

An estimated 225 million malaria cases occur worldwide annually, resulting in about 781,000 deaths each year, according to the World Health Organization. Although the disease is present in 106 countries around the world, most cases occur in sub-Saharan Africa. Treating bed nets and indoor walls with insecticides is the main prevention strategy in developing countries, but the Anopheles mosquitoes that transmit malaria are slowly becoming resistant to these insecticides, rendering them less effective.

"Because mosquitoes increasingly are evolving to evade the malaria control methods currently in use, NIAID-supported scientists are testing new, innovative ways to prevent malaria that we hope can be developed into tools that will be effective for years to come," says NIAID Director Anthony S. Fauci, M.D.

One of these new strategies is killing Anopheles mosquitoes by spraying them with the naturally occurring fungus, Metarhizium anisopliae. Previous studies have found that this method nearly eliminates disease transmission when mosquitoes are sprayed soon after acquiring the malaria parasite. However, this strategy is not sustainable in the long term. If treating mosquitoes with the fungus kills them before they have a chance to reproduce and pass on their susceptibility to the spray, mosquitoes resistant to the fungus, which would reproduce normally, will soon become predominant and the spray will no longer be effective.

Because of this, Dr. St. Leger and colleagues tried a more focused approach. Rather than developing fungi that rapidly kill the mosquito, they genetically modified M. anisopliae to block the development of the malaria parasite in the mosquito.

Eleven days after feeding on blood infected by the malaria parasite, mosquitoes were divided into three groups and either sprayed with naturally occurring M. anisopliae fungi, sprayed with genetically modified M. anisopliae fungi or not sprayed at all. Two weeks after exposing the mosquitoes to the malaria parasite, the researchers looked for the parasite on the salivary glands of mosquitoes in each of the three groups.

Compared with the other treatments, the modified M. anisopliae significantly reduced parasite development. The malaria parasite was found on the salivary glands of just 25 percent of the mosquitoes sprayed with the transgenic fungi, compared with 87 percent of those sprayed with the naturally occurring strain and 94 percent of unsprayed mosquitoes. The transgenic strain also reduced the density of parasites on the mosquitoes' salivary glands by more than 95 percent compared with the unmodified strain.

"The genes added to the transgenic fungi prevent the parasite from binding to the salivary glands of mosquitoes, so when a mosquito bites a human, the parasite is not transmitted," explains Adriana Costero-Saint Denis, Ph.D., of NIAID's Vector Biology Program (http://www.niaid.nih.gov/topics/vector/Pages/Default.aspx).

The researchers then used a model to estimate how well each fungus strain would reduce malaria transmission, and found that compared with the wild-type strain, the transgenic strain could reduce transmission to humans by fivefold, if not more.

"Our principal aim now is to get this technology into the field," says Dr. St. Leger. "We also would like to test some additional fungal variants to make sure we have the optimized malaria-blocking pathogen," he adds. Although they do not expect this technology to affect the environment any differently than the wild-type strain, the study authors plan to test ways to contain the transgenic fungi in the field.

### For more information, see the NIAID Malaria Web portal http://www.niaid.nih.gov/topics/malaria/Pages/default.aspx.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

Reference: W Fang et al. Development of transgenic fungi that kill human malaria parasites in mosquitoes. Science. DOI: 10.1126/science.1199115 (2011).

ELSE PRESS RELEASES FROM THIS DATE:

Drier conditions projected to accelerate dust storms in the southwest

2011-02-28

MOAB, Utah — Drier conditions projected to result from climate change in the Southwest will likely reduce perennial vegetation cover and result in increased dust storm activity in the future, according to a new study by scientists with the U.S. Geological Survey and the University of California, Los Angeles. The research team examined climate, vegetation and soil measurements collected over a 20-year period in Arches and Canyonlands National Parks in southeastern Utah. Long-term data indicated that perennial vegetation in grasslands and some shrublands declined with temperature ...

GSA Bulletin highlights: New research posted Feb. 4-11, 2011

2011-02-28

Boulder, CO, USA - GSA BULLETIN is now posting pre-issue publication content -- finalized papers that are ready to go to press and not under embargo. GSA invites you to sign up for e-alerts and be the first to have access to new journal content as it becomes available. Sign in at http://www.gsapubs.org/cgi/alerts with your e-mail address to manage subscriptions for pre-issue postings, full tables of contents alerts, and more. Keywords: Silicic calderas, Quaternary, Iberian Peninsula, Tsuboi's technique, Colorado River, Gran Desierto dune field, ASTER. Eel River, LiDAR, ...

Viral infection not responsible for exacerbation of lung disease in most patients

2011-02-28

Acute viral infection does not appear to be a primary cause of acute exacerbation of idiopathic pulmonary fibrosis (IPF), a progressive, deadly disease resulting in thickening and scarring of the lungs, according to a study conducted by researchers from the U.S., Korea and Japan. Previous studies had suggested viral infection might cause exacerbation of IPF in a majority of patients who have the condition, which occurs most often in people between 50 and 70 years of age. The findings were published online ahead of the print edition of the American Thoracic Society's American ...

New kind of optical fiber developed

2011-02-28

A team of scientists led by John Badding, a professor of chemistry at Penn State University, has developed the very first optical fiber made with a core of zinc selenide -- a light-yellow compound that can be used as a semiconductor. The new class of optical fiber, which allows for a more effective and liberal manipulation of light, promises to open the door to more versatile laser-radar technology. Such technology could be applied to the development of improved surgical and medical lasers, better countermeasure lasers used by the military, and superior environment-sensing ...

New way to identify patients at risk of dysphagia after head and neck cancer treatment

2011-02-28

At the 3rd International Conference on innovative approaches in Head and Neck Oncology (ICHNO), Dr Hanna Rahbek Mortensen and colleagues at hospitals and institutes in Denmark presented results from a large prospective trial, the DAHANCA 6 & 7 study. The study, conducted across the country, investigated risk factors for developing dysphagia (swallowing dysfunction), after undergoing radiotherapy treatment for a head & neck cancer. "We followed 1,476 patients with squamous cell carcinoma of the head and neck and found out the existence of factors related to the cancer itself, ...

Little historical evidence to support cutting global health aid during recessions

2011-02-28

Boston, MA – The World Bank and World Health Organization have voiced fears that policymakers will break their commitments to support desperately needed global health services in low- and middle-income countries because of the ongoing global economic downturn. Yet, according to a new study from the Harvard School of Public Health, there is surprisingly little historical evidence to justify reversing these commitments. "In order to achieve a sustainable economic recovery, governments must first take care of people's most basic health needs," said David Stuckler, assistant ...

Quick, easy test identifies aggressive type of lung cancer in never-smokers

2011-02-28

An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found. Dr Ping Yang from the Mayo Clinic, Rochester, USA, and colleagues, reported the findings at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO), 24-26 February 2011, Lugano, Switzerland. Approximately 8% - 12% of patients with lung adenocarcinoma who have never smoked cigarettes carry tumors that express a protein ...

Oncogene AEG-1 strongly predicts response to erlotinib treatment in EGFR-mutant lung cancer

2011-02-28

Spanish researchers have identified a gene whose expression level strongly predicts how well certain lung cancer patients will respond to treatment with the drug erlotinib. Dr Rafael Rosell and colleagues reported their findings at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO), 24-26 February 2011 in Lugano, Switzerland. The researchers studied 55 patients with non-small cell lung cancer, whose tumors had mutations in the epidermal growth factor receptor (EGFR) gene. All were being treated with the drug erlotinib, which acts on the EGFR molecule. "Currently ...

Bone drug zoledronic acid may help prevent spread of early lung cancer

2011-02-28

A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers have found. Dr Michela Quirino and colleagues from the Catholic University of the Sacred Heart in Rome have reported important new evidence that zoledronic acid may be able to prevent lung cancer metastases from recruiting the new blood vessels they need to survive. This process of recruiting new blood vessels is called angiogenesis. "Our investigation ...

Brain imaging provides window into consciousness

2011-02-28

NEW YORK (Feb. 25, 2011) -- Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness -- but the view it presents is one that is blurred in fascinating ways, say researchers at Weill Cornell Medical College in the Feb. 25 online edition of the journal Brain. In a novel study of six patients ranging in their function from minimally conscious state to the locked-in syndrome (normal cognitive function with severe motor impairment), the researchers looked at how the brains of ...

Adolescent boys who experience violence have up to 8 times the odds of perpetrating physical and sexual intimate partner violence that same day, per South African study collecting real-time data over

Critically endangered hawksbill turtles migrate up to 1,000km from nesting to foraging grounds in the Western Caribbean, riding with and against ocean currents to congregate in popular feeding hotspot

Genetically modified fungi kill malaria-causing parasites in mosquitoes

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: